FDA.reportPublic FDA data

inert ingredients 1 MG Disintegrating Oral Tablet

RxCUI
2696886
RxNorm name
inert ingredients 1 MG Disintegrating Oral Tablet
Display name
inert ingredients 1 MG Disintegrating Oral Tablet
Full name
inert ingredients 1 MG Disintegrating Oral Tablet
Term type
PSN
Status
DailyMed mapping
Updated
2026-06-04 23:39:12

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 0 matching rows.

No records found.

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 1 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
FEMLYVNORETHINDRONE ACETATE/ETHINYL ESTRADIOLMillicent US, Inc.a3c99fc1-9b05-4f0a-ad00-5e3e206302c92025-09-03Boxed warning, Warnings, Adverse reactionsExact identifier
rxcui: 2696886

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 1 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
a3c99fc1-9b05-4f0a-ad00-5e3e206302c9inert ingredients 1 MG Disintegrating Oral Tablet [PSN] · inert ingredients 1 MG Disintegrating Oral Tablet [SCD]23These highlights do not include all the information needed to use FEMLYV™ safely and effectively. See full prescribing information for FEMLYV. FEMLYV (norethindrone acetate and ethinyl estradiol orally disintegrating tablets) Initial U.S. Approval: 196820250903